Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: ColtonGang who wrote (41861)	10/3/2000 9:28:04 AM
From: Frank Griffin	Respond to of 769669

Cells Transplanted to Man's Heart PHILADELPHIA, Oct. 3, 2000 -- For the first time, doctors have transplanted a patient's own skeletal muscle onto his heart to see if similar tissue could one day be used to treat heart disease. Under the procedure, a small amount of muscle from a patient's arm was removed, grown in a lab for two weeks and then grafted to his heart. The 48-year-old patient is awaiting a heart transplant. The study, being conducted by Temple University and Diacrin Inc., is "primarily a safety study to see if the graft takes," said E. Michael Egan, vice president for corporate development at Boston-based Diacrin. "The patient becomes almost like a petri dish of his own," said Dr. Satoshi Furukawa, surgical director of the heart and lung transplant program at Temple. Researchers will monitor six patients in the study to better understand the safety of transplanting the cells and the potential benefits. They plan to analyze patients' hearts after transplant to examine the cells more closely. Preliminary studies on animals suggest that the transplanted muscle tissue may repair damaged heart muscle and strengthen heart contractions. "There are far more people who need heart transplants than there are donors," said Dr. Howard Eisen, the medical director of Temple's heart transplant program. "It's a patient's own cells, so there's no fear of rejection." Heart disease -- the nation's leading killer -- affects an estimated 12 million Americans. The ideal solution, which would be years away, is that a patient who has a heart attack would have muscle cells grafted to the heart to prevent further damage and even avert the need for a transplant, Egan said. One expert said the research holds promise. "If it's safe and feasible, then the next question will be how much impact it has and whether you can graft enough cells to substantially benefit patients," said Dr. Sidney C. Smith, a past president of the American Heart Association and a professor of medicine at the University of North Carolina. Using transplanted cells in lieu of a heart transplant is likely years away. "Will it happen in my lifetime? I'm not so sure. But there's potential," Furukawa said. --- --Associated Press Copyright © iSyndicate, Inc.